🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 8 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/12/2024 | 122,61 | 123,32 | 119,50 | 119,93 | -2,26% | 3,12% | 81.200 |
| 02/12/2024 | 121,99 | 124,00 | 119,18 | 122,70 | +1,01% | 3,95% | 83.400 |
| 29/11/2024 | 123,44 | 124,34 | 120,01 | 121,47 | -0,88% | 3,51% | 72.100 |
| 27/11/2024 | 123,65 | 125,00 | 121,06 | 122,55 | -1,43% | 3,19% | 88.900 |
| 26/11/2024 | 120,62 | 124,44 | 119,78 | 124,33 | +3,08% | 3,86% | 182.800 |
| 25/11/2024 | 119,74 | 122,63 | 119,04 | 120,62 | +1,20% | 3,00% | 153.700 |
| 22/11/2024 | 116,22 | 120,00 | 116,22 | 119,19 | +2,27% | 3,25% | 93.200 |
| 21/11/2024 | 112,80 | 118,12 | 112,06 | 116,55 | +4,47% | 5,37% | 83.400 |
| 20/11/2024 | 111,59 | 112,00 | 109,53 | 111,56 | -0,21% | 2,21% | 133.600 |
| 19/11/2024 | 110,72 | 112,27 | 109,78 | 111,80 | +0,12% | 2,25% | 98.200 |
| 18/11/2024 | 110,87 | 113,04 | 109,44 | 111,67 | -0,04% | 3,25% | 125.900 |
| 15/11/2024 | 116,52 | 116,52 | 110,32 | 111,71 | -3,24% | 5,32% | 107.800 |
| 14/11/2024 | 123,22 | 125,76 | 114,39 | 115,45 | -5,43% | 9,23% | 135.200 |
| 13/11/2024 | 122,00 | 123,72 | 120,99 | 122,08 | +1,11% | 2,24% | 219.100 |
| 12/11/2024 | 123,08 | 124,46 | 119,69 | 120,74 | -2,21% | 3,88% | 120.800 |
| 11/11/2024 | 122,24 | 124,19 | 120,83 | 123,47 | +1,83% | 2,75% | 209.200 |
| 08/11/2024 | 126,27 | 127,26 | 116,96 | 121,25 | -6,66% | 8,16% | 260.600 |
| 07/11/2024 | 118,33 | 129,90 | 115,16 | 129,90 | +11,12% | 12,46% | 271.800 |
| 06/11/2024 | 114,09 | 116,95 | 111,72 | 116,90 | +5,19% | 4,58% | 214.600 |
| 05/11/2024 | 109,57 | 111,59 | 108,31 | 111,13 | +0,83% | 2,99% | 86.400 |
| 04/11/2024 | 109,14 | 110,63 | 108,11 | 110,22 | +0,16% | 2,31% | 99.800 |
| 01/11/2024 | 107,05 | 110,79 | 107,05 | 110,04 | +4,11% | 3,49% | 121.400 |
| 31/10/2024 | 109,56 | 109,56 | 105,48 | 105,70 | -3,74% | 3,72% | 100.400 |
| 30/10/2024 | 114,93 | 115,10 | 109,81 | 109,81 | -4,95% | 4,60% | 63.900 |
| 29/10/2024 | 112,98 | 115,53 | 112,98 | 115,53 | +1,90% | 2,26% | 118.700 |
| 28/10/2024 | 113,26 | 113,51 | 110,00 | 113,38 | +1,40% | 3,10% | 206.900 |
| 25/10/2024 | 111,19 | 113,37 | 111,13 | 111,82 | +0,75% | 2,01% | 122.800 |
| 24/10/2024 | 106,89 | 111,04 | 106,32 | 110,99 | +3,84% | 4,42% | 145.000 |
| 23/10/2024 | 106,29 | 107,28 | 104,58 | 106,89 | +0,37% | 2,54% | 64.200 |
| 22/10/2024 | 106,19 | 106,51 | 104,29 | 106,50 | -0,26% | 2,09% | 68.800 |